Marshall Wace’s Semler Scientific SMLR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-77,448
| Closed | -$1.18M | – | 3645 |
|
|
2025
Q4 | $1.18M | Buy |
77,448
+62,076
| +404% | +$1.41M | ﹤0.01% | 1848 |
|
|
2025
Q3 | $461K | Buy |
+15,372
| New | +$529K | ﹤0.01% | 2264 |
|
|
2024
Q4 | – | Sell |
-18,841
| Closed | -$444K | – | 2975 |
|
|
2024
Q3 | $444K | Buy |
+18,841
| New | +$541K | ﹤0.01% | 1964 |
|
|
2024
Q2 | – | Sell |
-10,107
| Closed | -$295K | – | 2923 |
|
|
2024
Q1 | $295K | Sell |
10,107
-23,557
| -70% | -$983K | ﹤0.01% | 2119 |
|
|
2023
Q4 | $1.49M | Sell |
33,664
-14,726
| -30% | -$529K | ﹤0.01% | 1346 |
|
|
2023
Q3 | $1.23M | Buy |
48,390
+16,648
| +52% | +$433K | ﹤0.01% | 1428 |
|
|
2023
Q2 | $833K | Sell |
31,742
-1,445
| -4% | -$38.1K | ﹤0.01% | 1798 |
|
|
2023
Q1 | $889K | Buy |
+33,187
| New | +$930K | ﹤0.01% | 1871 |
|
|
2022
Q2 | – | Sell |
-10,309
| Closed | -$512K | – | 3815 |
|
|
2022
Q1 | $512K | Buy |
10,309
+7,472
| +263% | +$501K | ﹤0.01% | 2759 |
|
|
2021
Q4 | $260K | Buy |
+2,837
| New | +$318K | ﹤0.01% | 3075 |
|
Marshall Wace's SMLR Position: Q1 2026 in Review
Marshall Wace sold out of Semler Scientific (SMLR) in Q1 2026, closing a stake of 77,448 shares — an estimated $1.18M sold.
Marshall Wace first reported a position in SMLR in Q4 2021 and held it in 10 quarters. The position peaked at $1.49M in Q4 2023. 0 funds tracked by Wall St. Rank hold SMLR as of Q1 2026.
- Marshall Wace reported no remaining Semler Scientific position as of Q1 2026 after selling out during the quarter.
- Marshall Wace sold 77,448 Semler Scientific shares in Q1 2026, an estimated $1.18M.
- Marshall Wace first reported a position in Semler Scientific in Q4 2021 and held it in 10 quarters.
- Marshall Wace's Semler Scientific position peaked at $1.49M in Q4 2023.
- 0 funds tracked by Wall St. Rank held Semler Scientific as of Q1 2026.
Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.